Abstract
Although critical to T cell function, antigen specificity is often omitted in high-throughput multiomics-based T cell profiling due to technical challenges. We describe a high-dimensional, tetramer-associated T cell antigen receptor (TCR) sequencing (TetTCR-SeqHD) method to simultaneously profile cognate antigen specificities, TCR sequences, targeted gene expression and surface-protein expression from tens of thousands of single cells. Using human polyclonal CD8+ T cells with known antigen specificity and TCR sequences, we demonstrate over 98% precision for detecting the correct antigen specificity. We also evaluate gene expression and phenotypic differences among antigen-specific CD8+ T cells and characterize phenotype signatures of influenza- and Epstein–Barr virus-specific CD8+ T cells that are unique to their pathogen targets. Moreover, with the high-throughput capacity of profiling hundreds of antigens simultaneously, we apply TetTCR-SeqHD to identify antigens that preferentially enrich cognate CD8+ T cells in patients with type 1 diabetes compared to healthy controls and discover a TCR that cross-reacts with diabetes-related and microbiome antigens. TetTCR-SeqHD is a powerful approach for profiling T cell responses in humans and mice.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
All TCR and peptide information is in the supplementary tables. The accession number for raw sequencing data is phs002441.v1.p1 on dbGaP. Source data are provided with this paper.
Code availability
Custom analysis code is available on GitHub (https://github.com/JiangLabSysImmune).
References
Davis, M. M. & Boyd, S. D. Recent progress in the analysis of alphabetaT cell and B cell receptor repertoires. Curr. Opin. Immunol. 59, 109–114 (2019).
Pulendran, B. & Davis, M. M. The science and medicine of human immunology. Science 369, 1582–1593 (2020).
Satpathy, A. T. et al. Transcript-indexed ATAC-seq for precision immune profiling. Nat. Med. 24, 580–590 (2018).
Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865–868 (2017).
Peterson, V. M. et al. Multiplexed quantification of proteins and transcripts in single cells. Nat. Biotechnol. 35, 936–939 (2017).
Mair, F. et al. A targeted multi-omic analysis approach measures protein expression and low-abundance transcripts on the single-cell level. Cell Rep. 31, 107499 (2020).
Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 37, 1458–1465 (2019).
Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576–1588 (2019).
Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479–1495 (2020).
Li, G. et al. T cell antigen discovery via trogocytosis. Nat. Methods 16, 183–190 (2019).
Joglekar, A. V. et al. T cell antigen discovery via signaling and antigen-presenting bifunctional receptors. Nat. Methods 16, 191–198 (2019).
Kisielow, J., Obermair, F. J. & Kopf, M. Deciphering CD4+ T cell specificity using novel MHC-TCR chimeric receptors. Nat. Immunol. 20, 652–662 (2019).
Kula, T. et al. T-scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016–1028 (2019).
Sharma, G., Rive, C. M. & Holt, R. A. Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries. Nat. Commun. 10, 4553 (2019).
Ferretti, A. P. et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095–1107 (2020).
Newell, E. W. et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nat. Biotechnol. 31, 623–629 (2013).
Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575–579 (2018).
Zhang, S. Q. et al. High-throughput determination of the antigen specificities of T cell receptors in single cells. Nat. Biotechnol. 36, 1156–1159 (2018).
Rodenko, B. et al. Generation of peptide-MHC class I complexes through UV-mediated ligand exchange. Nat. Protoc. 1, 1120–1132 (2006).
Bender, C., Rajendran, S. & von Herrath, M. G. New insights into the role of autoreactive CD8 T cells and cytokines in human type 1 diabetes. Front Endocrinol. (Lausanne) 11, 606434 (2020).
Shahi, P., Kim, S. C., Haliburton, J. R., Gartner, Z. J. & Abate, A. R. Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding. Sci. Rep. 7, 44447 (2017).
Ma, K. Y. et al. Immune repertoire sequencing using molecular identifiers enables accurate clonality discovery and clone size quantification. Front. Immunol. 9, 33 (2018).
Gayoso, A. et al. Joint probabilistic modeling of single-cell multi-omic data with totalVI. Nat. Methods 18, 272–282 (2021).
McInnes, L., Healy, J. & Melville, J. Umap: uniform manifold approximation and projection for dimension reduction. Preprint at https://arxiv.org/abs/1802.03426 (2018).
Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184–197 (2015).
Pita-Lopez, M. L., Pera, A. & Solana, R. Adaptive memory of human NK-like CD8+ T-cells to aging, and viral and tumor antigens. Front. Immunol. 7, 616 (2016).
Keating, R. et al. Potential killers exposed: tracking endogenous influenza-specific CD8+ T cells. Immunol. Cell Biol. 96, 1104–1119 (2018).
Sharma, S. et al. T cell immunoglobulin and mucin protein-3 (Tim-3)/galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl Acad. Sci. USA 108, 19001–19006 (2011).
Ibegbu, C. C. et al. Differential expression of CD26 on virus-specific CD8+ T cells during active, latent and resolved infection. Immunology 126, 346–353 (2009).
Men, Y. et al. Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J. Immunol. 162, 3566–3573 (1999).
Derre, L. et al. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J. Immunol. 179, 7635–7645 (2007).
Dutoit, V. et al. Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer+ CD8+ T cells in humans. J. Exp. Med. 196, 207–216 (2002).
Blancou, P. et al. Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients. J. Immunol. 178, 7458–7466 (2007).
Abreu, J. R. et al. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin. Exp. Immunol. 170, 57–65 (2012).
Kracht, M. J. et al. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. Nat. Med. 23, 501–507 (2017).
Cole, D. K. et al. Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. J. Clin. Invest. 126, 3626 (2016).
Velthuis, J. H. et al. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers. Diabetes 59, 1721–1730 (2010).
Wiedeman, A. E. et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J. Clin. Invest. 130, 480–490 (2020).
Culina, S. et al. Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci. Immunol. 3, 20 (2018).
Shum, E. Y., Walczak, E. M., Chang, C. & Fan, H. C. in Single Molecule and Single Cell Sequencing (ed. Suzuki, Y.) 63–79 (Springer Singapore, 2019).
Yu, W. et al. Clonal deletion prunes but does not eliminate self-specific alphabeta CD8(+) T lymphocytes. Immunity 42, 929–941 (2015).
Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res 27, 491–499 (2017).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Wendel, B. S. et al. Accurate immune repertoire sequencing reveals malaria infection driven antibody lineage diversification in young children. Nat. Commun. 8, 531 (2017).
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360–3368 (2017).
Acknowledgments
We thank the patients with T1D for donating blood samples to our study. We also thank anonymous blood donors and staff members at We Are Blood for sample collection. We thank P. Parker for assistance with blood sample purification. We thank S. Chizari for assistance with uploading sequencing data to dbGaP and source code to GitHub. This work was supported by National Institutes of Health grants S10OD020072 (N.J.), R33CA225539 (N.J.) and R56AG064801 (N.J.); National Science Foundation CAREER award 1653866 (N.J.); Welch Foundation grant F1785 (N.J.); the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (N.J.); and the Chan Zuckerberg Initiative Neurodegeneration Challenge Network Ben Barres Early Career Acceleration Awards 191856 (N.J.). We would also like to acknowledge funding from the University of Texas at Austin Cockrell School of Engineering Fellowship (A.A.S.), Mario E. Ramirez Endowed Graduate Fellowship (A.A.S.) and the Harry and Rubye Gaston Graduate Scholarship (A.A.S.).
Author information
Authors and Affiliations
Contributions
K.-Y.M. and N.J. conceived and designed the study. K.-Y.M. designed and developed the technology platform; K.-Y.M. and A.A.S. performed and analyzed data for the majority of experiments; K.-Y.M. developed the pipeline to analyze tetramer DNA-barcode data; C.H. and K.-Y.M. developed the script for analyzing TCR sequence data; A.A.S., A.X., E.C., and Y.W.G. performed TCR transduction experiments; E.S. performed in vitro cell culture; A.A.S. and Y.W.G. performed tetramer staining and CD107α experiments. K.R.S. and M.K.-D. recruited patients with T1D and collected blood samples from them. R.B. provided help with Rhapsody-related experiments; K.-Y.M. and N.J. wrote the manuscript with help from all co-authors.
Corresponding author
Ethics declarations
Competing interests
N.J. is a scientific advisor and holds equity interest in ImmuDX and Immune Arch, companies that are developing products related to the research reported. R.B. is an employee of Becton Dickinson, which provided some of the equipment and reagents used in the study. The remaining authors declare no competing interests.
Additional information
Peer review information Nature Immunology thanks Iwijn De Vlaminck, Angela Wu, and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. L. A. Dempsey was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Tetramer-positive CD8+ T cells from a mixture of pMHC tetramer-sorted polyclonal T cells cultured in vitro and quality check of gene expression.
a, Gating strategy for sorting tetramer-positive CD8+ T cells from a mixture of pMHC tetramer sorted polyclonal T cells cultured in vitro. b,c, Distribution of mRNA counts (log10) (b) and number of detected genes per cell (c) among different antigen-specific T cell populations. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range.
Extended Data Fig. 2 Absolute expression (log10 of MID counts) of differentially expressed genes and surface proteins among different clusters.
a,b, Genes and surface protein plotted here are the same set as in Fig. 3d. c, Distributions of AbSeq MID counts for differentially expressed surface proteins shown in Fig. 3d. d, Density plot showing of all CD8 T cells by AbSeq MID counts of CD45RA vs. CD197, and CD28 vs. CD27, respectively. Colors represent the local density of cells on the two-dimensional space.
Extended Data Fig. 3 TetTCR-SeqHD enables combined gene expression, phenotype and TCR clonality comparison among antigen-specific CD8+ T cells.
a, UMAP of single cells among different donors. Grey dots represent all cells and colored dots are cells from different chips. b, Comparison of the distribution of phenotypes between tetramer-positive and tetramer-negative CD8+ T cells. c, Percentage of naive population in each antigen-specific CD8+ T cell group. d, Percentage breakdown of naive CD8+ T cells among all major antigen specificities. Only antigen specificities with a percentage greater than 1% within the naive population are shown. ‘NEG’ cells are tetramer-negative CD8+ T cells identified by tetramer MID counts. Cells were classified into filter category based on the following criteria: (1) more than one antigen binds to a single cell, and these antigens are a distance of more than 3 amino acids away from each other; (2) correlation of tetramer MID between single cells and the median of all cells with same TCR sequence is below 0.9, identified as described in Methods.
Extended Data Fig. 4 Distribution of representative tetramer MID counts.
a, Distribution of tetramer MID counts for eight antigen specificities, including EBV antigens (EBV-BLMF1, BZLF1-190-197, EBV-BRLF1 and EBV-LMP2A), influenza viral antigens (M1 and NP44-52), T1D-associated antigens (PTPRN-FGD-9 and ZNT8-115-123) or cross-reactive antigens (HCV, Mart1 and DUF5119-124-133/INSDRIP-1-9/PTPRN-797-805). For each cell in the group, the MID counts for each of the 280 antigens used in the experiment were tallied and then overlaid in the same order of the 280 antigens. Only the antigens that emerge after the filter are labeled on the x axis, and their position in the 280 antigen list is indicated by a tick on the x axis. Each panel with a sharp single peak indicated single antigen specificity, while panels with multiple sharp peaks indicated cross-reactive antigens. b, Comparison of tetramer MID counts among DUF5119-124-133/INSDRIP-1-9/PTPRN-797-805 cross-reactive and single antigen-specific cells.
Extended Data Fig. 5 Analysis of T cells with bound antigen specificity being mismatched HLA alleles.
a, Summary of percentage of antigen-specific T cells with mismatched HLA alleles in all donors. Combined percentages from two sources are presented (Discussion). b, Percentage of antigen-specific T cells with mismatched HLA alleles in each donor. Combined percentages of two sources are presented (Discussion). c, Comparison of phenotypes of cells with mismatched HLA alleles with the overall population. Gray dots represent all CD8+ T cells.
Extended Data Fig. 6 Distribution of viral antigen-specific CD8+ T cells among 12 primary CD8+ T cells clusters in all 18 donors when the tetramer-negative MID threshold was set to 15.
Distribution of viral antigen-specific CD8+ T cells among 12 primary CD8+ T cells clusters in all 18 donors when the tetramer-negative MID threshold was set to 15 (Methods).
Extended Data Fig. 7 Frequency of total T1D autoantigen-specific CD8+ T cells in healthy subjects and T1D patients.
a, Frequency of T1D autoantigen tetramer-positive CD8+ T cells in different donors for various HLA alleles. b, Comparison of total T1D autoantigen tetramer-positive CD8+ T cells between healthy and T1D donors for various HLA alleles. A two-sided Wilcoxon nonparametric test was performed. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range. The number of subjects with HLA-A01:01, A02:01 and B08:01 are 10, 12 and 10, respectively.
Extended Data Fig. 8 T1D autoantigens with different antigen-specific CD8+ T cell frequencies and clonality between healthy subjects and T1D patients.
a, Five T1D autoantigens were identified to have a significantly higher frequency of antigen-specific T cells in peripheral blood when the MID-negative threshold was set to 15. A two-sided Wilcoxon nonparametric test was performed. Horizontal lines represent 25th percentile, median and 75th percentile values, with whiskers extending to the farthest data point within a maximum of 1.5 × interquartile range. The number of subjects with HLA-A01:01, A02:01 and B08:01 are 10, 12 and 10, respectively. b, TCR clonality heatmap of T1D antigenic-specific T cells for each antigen/donor combination. Grey, no T cells were detected.
Extended Data Fig. 9 Comparison of T1D antigen-specific CD8+ T cells between T1D patients and healthy subjects.
a, UMAP of T1D antigen-specific CD8+ T cells in T1D patients and healthy subjects respectively. Colored dots are T1D antigen-specific CD8+ T cells, and gray dots are other cells. b, Comparison of the distribution of phenotypes among T1D antigen-specific CD8+ T cells in each donor. Wilcoxon test was performed, with no significance between T1D and healthy subjects in any cluster.
Extended Data Fig. 10 TCR specificity and cross-reactivity validation by tetramer staining.
Bar plot showing the percentage of tetramer-positive cells gated on TCRβhi fraction of the cells, corresponding to Fig. 5b. Tetramer staining experiments were performed in triplicate. A two-tailed Student’s t test was performed between cognate tetramer and each negative control for all TCRs. EBV-BLMF1: GLCTLVAML; INSDRIP-1-9: MLYQHLLPL; DUF5119-124-133: MVWGPDPLYV; PTPRN-797-805: MVWESGCTV; PTPRN-FGD-9: FGDHPGHSY; INS-WMR-8: WMRLLPLL. ns, not significant; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001.
Supplementary information
Supplementary Information
Supplementary Figures 1-8
41590_2021_1073_MOESM4_ESM.xlsx
Supplementary Table 1: Antigens used to sort and stimulate polyclonal CD8+ T cells. Supplementary Table 2: Sequencing metrics for all TetTCR-SeqHD experiments. Supplementary Table 3: Reference sequences of TCRβ for polyclonal CD8+ T cells. Supplementary Table 4: Endogenous and foreign antigens used in TetTCR-SeqHD experiments with primary CD8+ T cells. Supplementary Table 5: Healthy individuals without T1D and patients with T1D and T2D used in the TetTCR-SeqHD experiments. Supplementary Table 6: Number of antigens and cells detected for non-T1D endogenous, T1D, and viral antigens in each individual. Supplementary Table 7: Summary of transduced TCR sequences and their cognate antigen specificities. Supplementary Table 8: Oligonucleotide sequences used in TetTCR-SeqHD. Supplementary Table 9: Oligonucleotides used to label additional antibodies.
Source data
Source Data Fig. 2
Statistical source data.
Source Data Fig. 3
Statistical source data.
Source Data Fig. 4
Statistical source data.
Source Data Fig. 5
Statistical source data.
Source Data Extended Data Fig. 1
Statistical source data.
Source Data Extended Data Fig. 2
Statistical source data.
Source Data Extended Data Fig. 3
Statistical source data.
Source Data Extended Data Fig. 4
Statistical source data.
Source Data Extended Data Fig. 5
Statistical source data.
Source Data Extended Data Fig. 6
Statistical source data.
Source Data Extended Data Fig. 7
Statistical source data.
Source Data Extended Data Fig. 8
Statistical source data.
Source Data Extended Data Fig. 9
Statistical source data.
Source Data Extended Data Fig. 10
Statistical source data.
Rights and permissions
About this article
Cite this article
Ma, KY., Schonnesen, A.A., He, C. et al. High-throughput and high-dimensional single-cell analysis of antigen-specific CD8+ T cells. Nat Immunol 22, 1590–1598 (2021). https://doi.org/10.1038/s41590-021-01073-2
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41590-021-01073-2
This article is cited by
-
Antigen specificity shapes distinct aging trajectories of memory CD8⁺ T cells
Nature Communications (2025)
-
CD8 + T Cells in Gastrointestinal Cancer: a Perspective on Targeting MicroRNA
Journal of Molecular Medicine (2025)
-
Adaptive immune receptor repertoire analysis
Nature Reviews Methods Primers (2024)
-
FIPRESCI: droplet microfluidics based combinatorial indexing for massive-scale 5′-end single-cell RNA sequencing
Genome Biology (2023)
-
Applications of single-cell RNA sequencing in drug discovery and development
Nature Reviews Drug Discovery (2023)